theory clinical_31_6
imports Main

begin

typedecl entity
typedecl event

consts
  BetaCatenin :: "entity ⇒ bool"
  Gene :: "entity ⇒ bool"
  CyclinD1 :: "entity ⇒ bool"
  Expression :: "entity ⇒ bool"
  Activate :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  NecessaryFor :: "entity ⇒ entity ⇒ bool"
  CellProliferation :: "entity"
  Mutation :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Activity :: "entity ⇒ bool"
  Enhance :: "event ⇒ bool"
  LeadTo :: "event ⇒ event ⇒ bool"
  Promote :: "event ⇒ bool"
  Directly :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  DueTo :: "entity ⇒ entity ⇒ bool"
  Result :: "event ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cell :: "entity ⇒ bool"

(* Explanation 1: β-catenin activates the expression of many genes, including cyclin D1, which is necessary for cell proliferation. *)
axiomatization where
  explanation_1: "∃x y z e. BetaCatenin x ∧ Gene y ∧ CyclinD1 z ∧ Expression y ∧ Activate e ∧ Agent e x ∧ Patient e y ∧ NecessaryFor z CellProliferation"

(* Explanation 2: Activating mutations of CTNNB1 enhance the activity of β-catenin, leading to increased expression of genes like cyclin D1, which directly promotes cell proliferation. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2. Mutation x ∧ CTNNB1 y ∧ BetaCatenin z ∧ Gene w ∧ CyclinD1 w ∧ Activity z ∧ Enhance e1 ∧ Agent e1 x ∧ Patient e1 z ∧ LeadTo e1 e2 ∧ Expression w ∧ Promote e2 ∧ Agent e2 w ∧ Patient e2 CellProliferation ∧ Directly e2"

(* Explanation 3: Enhanced activity of β-catenin, due to activating mutations of CTNNB1, directly promotes cell proliferation via β-catenin. *)
axiomatization where
  explanation_3: "∃x y z e. Activity x ∧ BetaCatenin y ∧ Mutation z ∧ CTNNB1 z ∧ Promote e ∧ Agent e x ∧ Patient e CellProliferation ∧ Directly e ∧ Via e y ∧ DueTo x z"

(* Explanation 4: Activating mutations of CTNNB1 result in enhanced activity of β-catenin, which is necessary for the proliferation of cells. *)
axiomatization where
  explanation_4: "∃x y z e. Mutation x ∧ CTNNB1 y ∧ Activity z ∧ BetaCatenin z ∧ Result e ∧ Agent e x ∧ Patient e z ∧ NecessaryFor z CellProliferation"

theorem hypothesis:
  assumes asm: "Mutation x ∧ CTNNB1 y ∧ Cell z"
  (* Hypothesis: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
  shows "∃x y z e. Mutation x ∧ CTNNB1 y ∧ Cell z ∧ Proliferation z ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y"
proof -
  (* From the premise, we have known information about Mutation x, CTNNB1 y, and Cell z. *)
  from asm have "Mutation x ∧ CTNNB1 y ∧ Cell z" by meson
  
  (* Explanation 2 and Explanation 3 are relevant to derive the hypothesis. *)
  (* Explanation 2 provides a logical relation: Implies(D, E) and Implies(E, C) *)
  (* Explanation 3 provides a direct promotion of cell proliferation via β-catenin. *)
  
  (* From Explanation 2, we have: *)
  have "∃x y z w e1 e2. Mutation x ∧ CTNNB1 y ∧ BetaCatenin z ∧ Gene w ∧ CyclinD1 w ∧ Activity z ∧ Enhance e1 ∧ Agent e1 x ∧ Patient e1 z ∧ LeadTo e1 e2 ∧ Expression w ∧ Promote e2 ∧ Agent e2 w ∧ Patient e2 CellProliferation ∧ Directly e2" 
    sledgehammer
  
  (* From Explanation 3, we have: *)
  have "∃x y z e. Activity x ∧ BetaCatenin y ∧ Mutation z ∧ CTNNB1 z ∧ Promote e ∧ Agent e x ∧ Patient e CellProliferation ∧ Directly e ∧ Via e y ∧ DueTo x z" 
    <ATP>
  
  (* Using the logical relation Implies(D, C) from Explanation 2, we can infer cell proliferation occurs. *)
  then have "Proliferation z" <ATP>
  
  (* From Explanation 3, we can directly infer the promotion of cell proliferation via β-catenin. *)
  then have "Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y" <ATP>
  
  (* Combining all the information, we can conclude the hypothesis. *)
  then show ?thesis <ATP>
qed

end
